Cardiac arrest and the role of thrombolytic agents

Annals of Emergency Medicine

Volumn 35, Issue 5, 2000, Pages 472-480

  Newman, D H ^a   Greenwald, I ^a   Callaway, C W ^a  

^a Center for Emergency Medicine of Western Pennsylvania   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLEEDING; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FIBRINOLYTIC THERAPY; HEART ARREST; HUMAN; NEUROPROTECTION; PRIORITY JOURNAL; RESUSCITATION; STROKE;

EID: 0033872037     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0196-0644(00)70008-4     Document Type: Article

References (58)

1. Predictors of survival following in-hospital cardiopulmonary resuscitation. A moving target
2. SUPPORT investigators
3. Do advanced cardiac life support drugs increase resuscitation rates from in-hospital cardiac arrest?
4. Postdischarge survival and functional status following in-hospital cardiopulmonary resuscitation
5. Survival after cardiopulmonary resuscitation in the hospital
6. Improving neurologic outcomes after out-of-hospital cardiac arrest
7. Effectiveness of emergency medical services for victims of out-of-hospital cardiac arrest: A meta-analysis
8. The efficacy of an ACLS training program for resuscitation from cardiac arrest in a rural community
9. ACLS - does it really work?
10. Effects of adding links to 'the chain of survival' for prehospital cardiac arrest: A contrast in outcomes in 1975 and 1995 at a single institution
11. Do advanced cardiac life support drug increase resuscitation rates from in-hospital cardiac arrest?
12. Effect of advanced cardiac life support training on resuscitation efforts and survival in a rural hospital
13. Association of Drug Therapy with survival in cardiac arrest: Limited role of advanced cardiac life support drugs
14. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction, and side effects from 33 randomized controlled trials
15. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute acute myocardial infarction
16. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
17. Trial of tissue plasminogen activator for mortality reduction in acute acute myocardial infarction
18. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients
19. An international randomized trial comparing four thrombolytic strategies for acute acute myocardial infarction
20. Successful treatment of massive pulmonary embolism after 90-minute external cardiac massage
21. Einsatzmoglichkeiten der thrombolyse in der reanimation
22. Thrombolytic therapy of massive pulmonary embolism during prolonged cardiac arrest using recombinant tissue-type plasminogen activator
23. Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolism
24. Survival from catastrophic intraoperative pulmonary embolism
25. Successful thrombolysis with rt-PA after syncope and protracted cardiopulmonary resuscitation in massive pulmonary embolism
26. Succesful thrombolysis of a fulminant lung embolism during cardiopulmonary resuscitation
27. Successful resuscitation after bolus injection of tissue-type plasminogen activator in emergency admission
28. Bolus thrombolytic infusions during CPR for patients with refractory arrest rhythms: Outcome or a case series
29. The Thrombolysis in Myocardial Infarction trial
30. Western Washington Randomized Trial of Intracoronary Streptokinase in AMI
31. Optimal management of acute myocardial infarction requires early and complete reperfusion
32. Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest
33. Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis
34. Cerebral blood flow dynamics in hypotension and cardiac arrest
35. Research work on blood clotting system during cardiorespiratory resuscitation
36. No-reflow after cardiac arrest
37. Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: An experimental study in the cat
38. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus
39. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice
40. Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator
41. Recombinant tissue plasminogen activator reduces infarct size after reversible thread occlusion of middle cerebral artery in mice
42. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest N Engl J Med.
43. Sudden cardiac death
44. Sudden cardiac death
45. Risk for intracranial hemorrhage after tissue plasminogen activator teatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2
46. Safety ofthrombolysis in association with cardiopulmonary resuscitation
47. Thrombolytic therapy in patients requiring cardiopulmonary resuscitation
48. Frequency of complications of cardiopulmonary resuscitation after thrombolysis during acute myocardial infarction
49. Saftey and efficacy of thrombolysis for acute myocardial infarction in patients with prolonged cardiopulmonary resuscitation
50. Thrombolysis in acute myocardial infarction following prolonged cardiopulmonary resuscitation
51. Liver rupture after cardiopulmonary resuscitation in a patient receiving thombolytic therapy
52. Unusual bleeding complications of thrombolytic therapy after cardiopulmonary resuscitation
53. Recent changes in management of acute myocardial infarction: Implications for emergency care physicians
54. Acute and chronic pulmonary thromboembolism: Current perspectives, Part V: Management
55. Thrombolytic therapy in thrombosis: A national institutes of health consensus development conference
56. Guidelines for the early management of patients with acute myocardial infarction
57. Current status of thrombolysis in acute myocardial infarction
58. ACC/AHA guidelines for the management of patients with acute myocardial infarction